Scott W. Meacham
President, Pharmaceuticals - Region North America
In his role as President, Pharmaceuticals, Region North America, Scott Meacham is responsible for all commercial aspects of Fresenius Kabi’s pharmaceutical products including IV Generics, Parenteral nutrition, Enteral Nutrition, Colloids and Standard Solutions. His areas of responsibility include Sales, Marketing, Business Development Portfolio Management and Regulatory Affairs activities in the Pharmaceutical Division.
Scott joined Fresenius Kabi in 2005 to lead the Sales and National Accounts teams and has held various roles in the company including Executive Vice President & Chief Commercial Officer, and Senior Vice President, Sales and National Accounts.
Prior to joining Fresenius Kabi, Scott was with Baxter Healthcare as Vice President, National Accounts for the company's Renal Division, responsible for leading negotiations with national dialysis providers. He began his career at Abbott Laboratories, and served in various roles during his 18 years with the company, including Sales, Contract Analysis, Business Development, Marketing and Corporate Account responsibilities. He subsequently rose through the leadership ranks to Director of Sales for Abbott's Critical Care business unit.
Scott is a registered pharmacist and holds a Bachelor of Science in Pharmacy from